China Oncology

2022, 32 (4): 2-2.

Abstract ( 11) PDF (1263KB) ( 16 )

New strategies for combined with immunotherapy of clear cell renal cell carcinoma: advances in aerobic glycolysis

SU Jiaqi, XU Wenhao, TIAN Xi, ANWAIE Aihetaimujiang, QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei

2022, 32 (4): 287-297. doi: 10.19401/j.cnki.1007-3639.2022.04.001

Abstract ( 59) PDF (1187KB) ( 47 ) HTML ( 19 )

CircSMARCA5 inhibits glycolysis and suppresses proliferation and invasion of gastric cancer cells through miR-4295/PTEN axis

CAI Juan, CHEN Zhiqiang, ZUO Xueliang

2022, 32 (4): 298-308. doi: 10.19401/j.cnki.1007-3639.2022.04.002

Abstract ( 45) PDF (2995KB) ( 56 ) HTML ( 14 )

Value of pretreatment ¹⁸F-FLT PET/CT and ¹⁸F-FDG PET/CT uptake heterogeneity for early prediction of treatment outcome in locally advanced nasopharyngeal carcinoma

MA Guang, OU Xiaomin, HU Chaosu, SONG Shaoli, YANG Zhongyi

2022, 32 (4): 309-315. doi: 10.19401/j.cnki.1007-3639.2022.04.003

Abstract ( 35) PDF (1186KB) ( 24 ) HTML ( 18 )

A study on correlation of acetyltransferase KAT3b and ABCE1 acetylation in esophageal cancer

LIANG Zongying, YANG Yang, SUN Guangrui, ZHAO Baoshan, XIN Guohua, ZHANG Le, HOU Jishen

2022, 32 (4): 316-323. doi: 10.19401/j.cnki.1007-3639.2022.04.004

Abstract ( 26) PDF (1872KB) ( 40 ) HTML ( 14 )

The association between cervical lesions of different grades and lncRNA HOTTIP and H19 single nucleotide polymorphisms

WANG Chuntao, GE Anxing, WU Hongyan, ZHANG Xueyan, YANG Sheng, YUAN Hongxiang, CHENG Yanping, FENG Yanlu, LU Xinyuan, LIANG Geyu

2022, 32 (4): 324-334. doi: 10.19401/j.cnki.1007-3639.2022.04.005

Abstract ( 26) PDF (1385KB) ( 25 ) HTML ( 16 )

Advances in the diagnosis of pathological response by a second biopsy in breast cancer neoadjuvant therapy and their clinical significance

XU Bingqi, ZHANG Guoqiang

2022, 32 (4): 335-342. doi: 10.19401/j.cnki.1007-3639.2022.04.006

Abstract ( 71) PDF (946KB) ( 65 ) HTML ( 18 )

Research progress in predicting the risk of lymphatic or hematologic metastasis based on chest CT in early non-small cell lung cancer

FU Yuanyuan, HOU Runping, FU Xiaolong

2022, 32 (4): 343-350. doi: 10.19401/j.cnki.1007-3639.2022.04.007

Abstract ( 59) PDF (1007KB) ( 27 ) HTML ( 14 )

The role and application value of integrin β3 in bone metastasis of lung adenocarcinoma

MU Jiaqian, TENG Xiaoyan, WEI Lirong, QIU Rong, GUI Pengcheng, DU Yuzhen

2022, 32 (4): 351-356. doi: 10.19401/j.cnki.1007-3639.2022.04.008

Abstract ( 38) PDF (2297KB) ( 31 ) HTML ( 82 )

Prognostic factor analysis of surgical treatment for cerebellar metastases in 36 patients

ZHOU Changshuai, YANG Yuechao, CUI Huanhuan, CHEN Lei, CHEN Xin, HAO Bin, TONG Tong, CAO Yiqun

2022, 32 (4): 357-362. doi: 10.19401/j.cnki.1007-3639.2022.04.009

Abstract ( 25) PDF (1187KB) ( 33 ) HTML ( 80 )

Screening and early diagnosis of breast cancer in China: a practice guideline

The Society of Breast Cancer, China Anti-Cancer Association

2022, 32 (4): 363-372. doi: 10.19401/j.cnki.1007-3639.2022.04.010

Abstract ( 95) PDF (1025KB) ( 169 ) HTML ( 90 )

Cover and contents

2022 Issue 4 Cover

Contents of Issue 4, 2022

Specialists' Commentary